November 4, 2025 - 14:07

Lummus Technology has officially announced the appointment of Erika Taurel as its new Chief Financial Officer. This strategic decision comes as the company aims to enhance its financial leadership and drive growth in the evolving energy sector. Taurel brings a wealth of experience to the role, having previously held various senior financial positions in prominent organizations.
In her new capacity, Taurel will oversee all financial operations, including financial planning, reporting, and risk management. Her extensive background in finance and her proven track record of driving operational efficiency are expected to contribute significantly to Lummus Technology's objectives.
The board of directors expressed confidence in Taurel’s ability to navigate the complexities of the current market landscape. As the energy industry continues to transition towards more sustainable practices, her expertise will be crucial in guiding the company through its financial strategies and ensuring long-term success.
Taurel's appointment marks a pivotal moment for Lummus Technology as it seeks to solidify its position as a leader in process technologies and energy solutions.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...